Congestion and sleep impairment in allergic rhinitis

Timothy Craig, Amir Sherkat, Sahar Safaee

Research output: Contribution to journalReview article

40 Citations (Scopus)

Abstract

Allergic rhinitis is a prevalent disease in developed nations, and its prevalence has been increasing throughout the world. Nasal congestion is the most common and bothersome symptoms of rhinitis. Congestion is associated with sleep-disordered breathing and is thought to be a key cause of sleep impairment in individuals with rhinitis. The end result is a decrease in quality of life and productivity and an increase in daytime sleepiness. Treatment with intranasal corticosteroids has been shown to reduce nasal congestion. Data on sleep-related end points from clinical trials of intranasal corticosteroids indicate that this reduction is associated with improved sleep, reduced daytime fatigue, and improved quality of life. Other therapies, such as montelukast, also have a positive influence on congestion and sleep. This review examines nasal congestion and the associated sleep impairment of allergic rhinitis patients. It explores the adverse effects of disturbed sleep on quality of life and how these conditions can be reduced by therapies that decrease congestion.

Original languageEnglish (US)
Pages (from-to)113-121
Number of pages9
JournalCurrent Allergy and Asthma Reports
Volume10
Issue number2
DOIs
StatePublished - Mar 1 2010

Fingerprint

Sleep
Nose
montelukast
Quality of Life
Rhinitis
Adrenal Cortex Hormones
Sleep Apnea Syndromes
Developed Countries
Fatigue
Allergic Rhinitis
Therapeutics
Clinical Trials

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Pulmonary and Respiratory Medicine

Cite this

Craig, Timothy ; Sherkat, Amir ; Safaee, Sahar. / Congestion and sleep impairment in allergic rhinitis. In: Current Allergy and Asthma Reports. 2010 ; Vol. 10, No. 2. pp. 113-121.
@article{04680ff1cbe4463198dd84a8356ffafe,
title = "Congestion and sleep impairment in allergic rhinitis",
abstract = "Allergic rhinitis is a prevalent disease in developed nations, and its prevalence has been increasing throughout the world. Nasal congestion is the most common and bothersome symptoms of rhinitis. Congestion is associated with sleep-disordered breathing and is thought to be a key cause of sleep impairment in individuals with rhinitis. The end result is a decrease in quality of life and productivity and an increase in daytime sleepiness. Treatment with intranasal corticosteroids has been shown to reduce nasal congestion. Data on sleep-related end points from clinical trials of intranasal corticosteroids indicate that this reduction is associated with improved sleep, reduced daytime fatigue, and improved quality of life. Other therapies, such as montelukast, also have a positive influence on congestion and sleep. This review examines nasal congestion and the associated sleep impairment of allergic rhinitis patients. It explores the adverse effects of disturbed sleep on quality of life and how these conditions can be reduced by therapies that decrease congestion.",
author = "Timothy Craig and Amir Sherkat and Sahar Safaee",
year = "2010",
month = "3",
day = "1",
doi = "10.1007/s11882-010-0091-5",
language = "English (US)",
volume = "10",
pages = "113--121",
journal = "Current Allergy and Asthma Reports",
issn = "1529-7322",
publisher = "Current Medicine Group",
number = "2",

}

Congestion and sleep impairment in allergic rhinitis. / Craig, Timothy; Sherkat, Amir; Safaee, Sahar.

In: Current Allergy and Asthma Reports, Vol. 10, No. 2, 01.03.2010, p. 113-121.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Congestion and sleep impairment in allergic rhinitis

AU - Craig, Timothy

AU - Sherkat, Amir

AU - Safaee, Sahar

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Allergic rhinitis is a prevalent disease in developed nations, and its prevalence has been increasing throughout the world. Nasal congestion is the most common and bothersome symptoms of rhinitis. Congestion is associated with sleep-disordered breathing and is thought to be a key cause of sleep impairment in individuals with rhinitis. The end result is a decrease in quality of life and productivity and an increase in daytime sleepiness. Treatment with intranasal corticosteroids has been shown to reduce nasal congestion. Data on sleep-related end points from clinical trials of intranasal corticosteroids indicate that this reduction is associated with improved sleep, reduced daytime fatigue, and improved quality of life. Other therapies, such as montelukast, also have a positive influence on congestion and sleep. This review examines nasal congestion and the associated sleep impairment of allergic rhinitis patients. It explores the adverse effects of disturbed sleep on quality of life and how these conditions can be reduced by therapies that decrease congestion.

AB - Allergic rhinitis is a prevalent disease in developed nations, and its prevalence has been increasing throughout the world. Nasal congestion is the most common and bothersome symptoms of rhinitis. Congestion is associated with sleep-disordered breathing and is thought to be a key cause of sleep impairment in individuals with rhinitis. The end result is a decrease in quality of life and productivity and an increase in daytime sleepiness. Treatment with intranasal corticosteroids has been shown to reduce nasal congestion. Data on sleep-related end points from clinical trials of intranasal corticosteroids indicate that this reduction is associated with improved sleep, reduced daytime fatigue, and improved quality of life. Other therapies, such as montelukast, also have a positive influence on congestion and sleep. This review examines nasal congestion and the associated sleep impairment of allergic rhinitis patients. It explores the adverse effects of disturbed sleep on quality of life and how these conditions can be reduced by therapies that decrease congestion.

UR - http://www.scopus.com/inward/record.url?scp=77952242567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952242567&partnerID=8YFLogxK

U2 - 10.1007/s11882-010-0091-5

DO - 10.1007/s11882-010-0091-5

M3 - Review article

C2 - 20425503

AN - SCOPUS:77952242567

VL - 10

SP - 113

EP - 121

JO - Current Allergy and Asthma Reports

JF - Current Allergy and Asthma Reports

SN - 1529-7322

IS - 2

ER -